mapping the effectiveness and risks of glp-1 receptor agonists Comparative on glycaemic control, body weight, lipid profile for type 2 diabetes: systematic review and network meta-analysis Author Correction: Mapping the effectiveness

This work was supported by a Grant-in-Aid for Scientific Research from JSPS (13J09842 to S.K., 23KJ0409 to N.A., 22K06075 to A.S., and 26113003, 26220205 and 18H05272 to T.S.), the Cooperative Research Program of NJRC Mater

It is available only through specialized research programs or specific compounding pharmacies under a doctors strict medical supervision

doi:10.1155/2013/767482 Shoemaker RC, House DE

BMI alone is misleading

After oral administration of a 100 mg dose to healthy subjects, sitagliptin was rapidly absorbed, with peak plasma concentrations (median Tmax) occurring 1 to 4 hours postdose

Were doing it because different brand names of the same generic medication have been approved for different indications, so we dont want to cause confusion